Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Belsomra (suvorexant) for the Treatment of Insomnia

Drug Name (Brand/Generic)

Belsomra (suvorexant)

Company/Licensee

Merck

Therapy Class

Selective antagonist

Current Indication

Insomnia characterised by difficulties with sleep onset or sleep maintenance

Market Sector

Central nervous system (CNS)

Development Status

Approved in the US
Expand

Go Top